Performa HargaHarga kembali 1 minggu9.25%
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)7.46
Harga Terendah (52 Minggu)5.84
Latar Belakang Perusahaan
Perusahaan bioteknologi yang mengembangkan terapi gen untuk pengobatan penyakit genetik langka dan kondisi medis dengan kebutuhan tinggi.
Summary
Valuation Information
Current PE Ratio (TTM)7.83
Forward PE Ratio526.32
Current Price to Book Value2.91
Current Price to Sales27.96
EV to Revenue15.19
EV to EBITDA3
PEG Ratio-
Per Share
Current EPS (Annualized)0.95
Diluted EPS (TTM)0.95
Revenue Per Share0.26
Current Book Value Per Share2.54
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-90049000
Profit Margin4.549
Operating Margin-2.641
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
